Hengrui and Kailera Announce Positive Phase II Results for HRS9531 in Weight Loss
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) and its US partner Kailera Therapeutics, Inc....
Gentize Biopharma Raises $13.64M in Pre-Series A for Vaccine Development
Gentize Biopharma, a clinical-stage vaccine developer based in Nanjing, has reportedly raised close to RMB...
Roche’s VENTANA Kappa and Lambda Dual ISH Test Gains FDA Clearance
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced that it has received marketing...
Illumina Partners with NVIDIA to Advance Multiomic Data Analysis
US-based genomics giant Illumina (NASDAQ: ILMN) has announced a strategic partnership with chip manufacturer NVIDIA...
Leqembi Autoinjector Advances with FDA Review for Alzheimer’s Treatment
Partners Eisai Co., Ltd (TYO: 4523) and Biogen Inc. (NASDAQ: BIIB) have announced that the...
Mediar Therapeutics and Eli Lilly Ink Deal for IPF Drug MTX-463
US-based clinical-stage biotech Mediar Therapeutics, Inc. has announced a global license agreement with Eli Lilly...
Cornerstone Robotics Raises $68.2M in Series C to Advance Surgical Robots
Cornerstone Robotics, an innovative surgical robot developer based in Shenzhen, has reportedly raised over RMB...
MGI Tech’s DNBSEQ-E25 Receives NMPA License as World’s First Self-Luminescent Sequencer
China-based gene sequencing specialist MGI Tech Co., Ltd has announced that it has received a...
Medtronic’s BrainSense Technologies Win EU, UK CE Mark for Parkinson’s Treatment
US-Irish firm Medtronic (NYSE: MDT) has announced that it has received CE (Conformité Européenne) Mark...
Sansure Biotech to Acquire Sinobioway Hygene for $110M to Boost Product Pipeline
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced plans to acquire 100%...
Novo Nordisk Launches Rybelsus in China, World’s First Oral GLP-1RA
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has announced the commercial launch of its innovative...
Merck’s Keytruda Gains NMPA Approval for HNSCC Indication in China
US-based Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) has announced that it has received...
Huadong Medicine Gets FDA Nod for Phase I Study of HDM2006 in Solid Tumors
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced that it has received approval from...
Zhaoke Ophthalmology Partners with AFT for Brimochol PF Distribution in ANZ
China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced a strategic distribution and supply agreement with...
Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss
China-based Tonghua Dongbao Pharmaceuticals (SHA: 600867) has announced a significant milestone in its clinical development...
Neo Modulus Secures $40.9M Series C Funding for Regenerative Medical Devices
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd., a prominent developer of regenerative implantable medical devices...
MediLink Therapeutics and AstraZeneca Collaborate on YL201 and Imfinzi Combo for Solid Tumors
Suzhou-based biotech company MediLink Therapeutics (Suzhou) Co., Ltd has announced a clinical cooperation agreement with...
Simcere Zaiming and AbbVie Ink $1.055B License Deal for MM Drug SIM0500
China-based Simcere Pharmaceutical Group Ltd (HKG: 2096) has announced a significant strategic move through its...
CSPC’s Prusogliptin Approved in China for Type 2 Diabetes Treatment
China’s National Medical Products Administration (NMPA) has granted marketing approval to CSPC Pharmaceutical Group Co.,...
3SBio Acquires Licensing Rights to Duality Biologics’ HER2-Targeting ADC DB-1303
China-based 3SBio Inc. (HKG: 1530) has entered into a strategic partnership with Duality Biologics, a...